Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September 2024 as against Rs 51.80 crore during the previous quarter ended September 2023. Sales rose 4.15% to Rs 458.03 crore in the quarter ended September 2024 as against Rs 439.80 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 458.03 | 439.80 | 4 |
| OPM % | 20.45 | 20.01 | - |
| PBDT | 92.65 | 85.08 | 9 |
| PBT | 71.77 | 66.94 | 7 |
| NP | 54.62 | 51.80 | 5 |